News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aastrom Biosciences, Inc. (ASTM) to Present at the 23rd Annual Oppenheimer Healthcare Conference


12/10/2012 9:06:14 AM

ANN ARBOR, Mich., Dec. 10, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that Chief Commercial Officer Dan Orlando will present at the 23rd Annual Oppenheimer Healthcare Conference at the Waldorf Astoria in New York City.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES